Contact us for free information or to start a free case review.
In November 2000, the FDA asked companies using PPA (phenlypropanolamine) in their cold products to voluntarily take the products off the market because of possible health risks, including links with hemorrhagic stroke in first time female users. Now, Bayer has lost the first of 1,500 PPA claims against the company after a Texas jury awarded $400,000 to a man who claims he had a stroke after taking Bayer AG''s Alka-Seltzer Plus cold medicine.
Of the 1,500 PPA cases pending, 700 of them are exclusively against Bayer. Bayer is considering whether to appeal the Texas ruling, as this jury award comes after the company is recovering from litigation over its recalled anti-cholesterol drug Baycol. Bayer had agreed to pay more than $1 billion to settle Baycol cases, which was withdrawn in 2001 and has been linked to 100 deaths.
An HVB analyst, Andreas Heine said in a note that if Bayer had to pay the same amount in every PPA case it was exclusively named, the total cost for the company would be $346 million. Heine also said the PPA cases were covered by the same insurance as the Baycol cases, but coverage was being used entirely on Baycol and nothing was left for PPA cases. Bayer has said insurance coverage was “presently provided for the PPA litigation” but that it was not possible to estimate potential PPA liability accurately.
On another note, Bayer has just pleaded guilty and agreed to pay $4.7 million for fixing synthetic rubber prices, the third time this year the company or a subsidiary admitted violating antitrust laws.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.